Clinical Report: Comparing Active Monitoring and Surgical Intervention for PTMC

Overview

This study investigates treatment approaches for adult low-risk papillary thyroid microcarcinoma (PTMC) in southern China, revealing significant variability in management strategies. Active surveillance (AS) has been adopted by over one-third of patients, but institutional differences in protocols and recommendations persist.

Background

The management of papillary thyroid microcarcinoma (PTMC) is a contentious issue due to its generally indolent nature and low mortality rate. With increasing incidence rates, understanding optimal treatment strategies, including active surveillance and surgical intervention, is crucial for patient outcomes. This study highlights current practices and the need for standardized guidelines in managing low-risk PTMC.

Data Highlights

Key Findings

• 36.1% of institutions left treatment decisions to patients.
• 48.1% of patients underwent immediate surgery as initial treatment.
• 28.0% of patients initially managed with AS subsequently required surgery.
• AS was more commonly recommended in tertiary hospitals.
• Significant variability exists in AS protocols across institutions.

Clinical Implications

Clinicians should be aware of the variability in treatment approaches for low-risk PTMC and the importance of shared decision-making with patients. Strengthening educational efforts and developing standardized guidelines are essential for improving management practices.

Conclusion

The findings underscore the need for a more uniform approach to managing low-risk PTMC, emphasizing the role of active surveillance while addressing clinician concerns and patient preferences.

Related Resources & Content

1. Frontiers in Surgery, 2026 -- Radiofrequency Ablation (RFA) of Papillary Thyroid Microcarcinoma (PTMC)
2. Investigating Active Surveillance Strategies for Papillary Microcarcinoma of the Thyroid in Clinical Trials
3. Factors Influencing Progression During Active Monitoring of Low-Risk Papillary Thyroid Microcarcinoma in Adults
4. The Journal of Clinical Endocrinology & Metabolism, 2025 -- Validation of the ATA Risk Assessment for Papillary Thyroid Microcarcinoma
5. Endocrinol Metab 2025;40:307-341
6. NCCN Guidelines for Thyroid Carcinoma 2025
7. Korean Thyroid Association AS Guidelines 2025
8. Long-Term Outcomes of Active Surveillance and Immediate Surgery for Adult Patients with Low-Risk Papillary Thyroid Microcarcinoma: 30-Year Experience - PMC
9. https://synapse.koreamed.org/upload/synapsexml/2008enm/pdf/enm-2025-2461.pdf
10. Size Increment During Surveillance in Papillary Thyroid Cancer: Evidence Synthesis and Dose–Response Meta‐Analysis - PMC
11. Patient-Reported Outcomes Across Treatment Strategies in Papillary Thyroid Microcarcinoma